In our cohort, the majority of RB tumors demonstrated MYCN and SYK promoter DNA hypomethylation (associated with gene activation); this profile was similarly identified in all AH samples as compared to apparently normal retinal tissues (Fig. 3C), suggesting that these targets can be detected via AH methylation profiling. Here, MYCN is linked to retinoblastoma.